Skip to main content
    U

    United Therapeutics Corporation (UTHR)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $584.10
    -3.78 (-0.64%)

    Market Cap: $25.04B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    United Therapeutics Corporation (UTHR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    United Therapeutics (UTHR) has a latest price of $584.10 on Nov 17, 2026, 4.9% below its 52-week high of $614.23. Its price rose 25.2% over the past 12 months. The month-end price rose 398.6% over the 10 years through Oct 2026, a compound annual rate of 17.4%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $598.72 in Oct 2026 and its lowest $78.06 in Jun 2019, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart UTHR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for UTHR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 10.4%, and over 6 months it rose 3.1%. The month-end price rose 168.7% over the 3 years through Oct 2026, a compound annual rate of 39.0%.

    PeriodChange
    1 month+7.5%
    3 months+10.4%
    6 months+3.1%
    12 months+25.2%
    12 months, with dividends+25.2%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+168.7%+39.0%
    5 years+213.9%+25.7%
    10 years+398.6%+17.4%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 72.3%, and its weakest was 2018, when it fell 26.4%.

    YearCloseChange
    2026 through Oct 2026$598.72+22.9%
    2025$487.25+38.1%
    2024$352.84+60.5%
    2023$219.89-20.9%
    2022$278.09+28.7%
    2021$216.08+42.4%
    2020$151.79+72.3%
    2019$88.08-19.1%
    2018$108.90-26.4%
    2017$147.95+3.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.9% above its 50-day average of $546.33 and 8.4% above its 200-day average of $538.59.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$584.10
    52-week high$614.23-4.9%
    52-week low$455.63+28.2%
    50-day average$546.33+6.9%
    200-day average$538.59+8.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 33.0%.

    MeasureValue
    1-year beta0.43
    Largest fall, 1 year-20.9%
    Largest fall, 3 years-33.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    United Therapeutics traded at 17.5x earnings at the end of 2025, against a 5-year median of 14.6x and a 10-year median of 12.4x.

    UTHR valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About UTHR

    What is UTHR's 1-year price change?

    United Therapeutics's price rose 25.2% over the past 12 months. With dividends included, the 12-month total return was 25.2%.

    What is UTHR's 5-year price change?

    United Therapeutics's month-end price rose 213.9% over the 5 years through Oct 2026, a compound annual rate of 25.7%. These figures leave out dividends.

    What is UTHR's 52-week high and low?

    United Therapeutics's 52-week high is $614.23 and its 52-week low is $455.63. Its latest price of $584.10 on Nov 17, 2026 is 4.9% below the high.

    What is UTHR's beta?

    United Therapeutics's 1-year beta against the S&P 500 is 0.43, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 20.9%.

    Is the UTHR chart free?

    Yes. Advanced Charting for UTHR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.